Traphagen Investment Advisors »

Rani Therapeutics Hldgs shares owned by Traphagen Investment Advisors

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Traphagen Investment Advisors from 13F filings

Historical chart of Traphagen Investment Advisors investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Traphagen Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Traphagen Investment Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $16k 22k 0.73

More positions owned by Traphagen Investment Advisors

Ishares Tr Core S&p500 Etf (IVV)
American Centy Etf Tr Us Eqt Etf (AVUS)
Victory Portfolios Ii Shares Free Cash (VFLO)
Janus Detroit Str Tr Henderson Securi (JSI)
First Tr Exchange-traded Nasdq Cln Edge (GRID)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Tortoise Capital Series Trus North Amrcn Pipe (TPYP)
Apple (AAPL)
Victory Portfolios Ii Victoryshares Fr (GFLW)
Pacer Fds Tr Us Lrg Cp Cash (COWG)
Fidelity Covington Trust Enhanced Intl (FENI)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Fidelity Covington Trust Msci Utils Index (FUTY)
Vaneck Etf Trust Alternative Asse (GPZ)

View all positions for Traphagen Investment Advisors

Top funds holding Rani Therapeutics Hldgs

RA Capital Management
Samsara BioCapital
AWM Investment Company
Vanguard Group
Vanguard Capital Management
SymBiosis Capital Partners
Longaeva Partners
Susquehanna International
Siren
Geode Capital Management
BlackRock
Nan Fung Group Holdings
683 Capital Management
Vanguard Fiduciary Trust
Millennium Management

View all funds holding Rani Therapeutics Hldgs